MetaADEDB 2.0 @ LMMD
Paliperidone Palmitate
(PMXMIIMHBWHSKN-UHFFFAOYSA-N)
Structure
SMILES
Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2O
Type(s)
Approved
ATC code(s)
N05AX13
Molecular Formula:
C23H27FN4O3
Molecular Weight:
426.484
Log P:
3.0192
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
84.39
CAS Number(s):
130049-84-2; 144598-75-4
Synonym(s)
1.
Paliperidone Palmitate
2.
3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3.
9-Hydroxy-risperidone
4.
9-Hydroxyrisperidone
5.
9-OH-risperidone
6.
Invega
7.
Invega Sustenna
8.
Paliperidone
9.
R 76477
10.
R-76477
11.
9 Hydroxy risperidone
12.
9 Hydroxyrisperidone
13.
9 OH risperidone
14.
Palmitate, Paliperidone
15.
R76477
16.
Sustenna, Invega
External Link(s)
MeSHD000068882
PubChem Compound115237
BindingDB50252513
ChEBI83804
CHEMBLCHEMBL1621
DrugBankDB01267
DrugCentral4137
IUPHAR/BPS Guide to PHARMACOLOGY7258
KEGGcpd:C21516
dr:D05339
Therapeutic Target DatabaseD0B3UJ
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 147
Canada Vigilance: 7
Canada Vigilance
US FAERS
2Blood prolactin increasedFAERS: 115
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
3Drug dose omissionFAERS: 108US FAERS
4DystoniaFAERS: 90OFFSIDES
US FAERS
5DizzinessFAERS: 81
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
6Emotional disorderFAERS: 80
Canada Vigilance: 1
Canada Vigilance
US FAERS
7TremorFAERS: 78
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8AnxietyFAERS: 72
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
9AkathisiaFAERS: 70
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
10Suicide attemptFAERS: 70US FAERS
11Adverse eventFAERS: 64US FAERS
12TachycardiaFAERS: 64
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
13SchizophreniaFAERS: 62
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
14SomnolenceFAERS: 60
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
15HeadacheFAERS: 58
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
16Tardive DyskinesiaFAERS: 56
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
17FatigueFAERS: 49
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
18NauseaFAERS: 49SIDER
US FAERS
19AgitationFAERS: 48
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
20Feeling abnormalFAERS: 43SIDER
US FAERS
21Inappropriate schedule of drug administrationFAERS: 43OFFSIDES
US FAERS
22Wrong technique in drug usage processFAERS: 42OFFSIDES
US FAERS
23VomitingFAERS: 40
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
24RestlessnessFAERS: 39US FAERS
25Completed SuicideFAERS: 37SIDER
US FAERS
26Musculoskeletal stiffnessFAERS: 37OFFSIDES
SIDER
US FAERS
27Product use issueFAERS: 37US FAERS
28OverdoseFAERS: 33US FAERS
29MalaiseFAERS: 32
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
30PalpitationsFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
31AstheniaFAERS: 31
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
32Neuroleptic Malignant SyndromeFAERS: 31SIDER
US FAERS
33Abnormal weight gainFAERS: 30US FAERS
34Product use in unapproved indicationFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
35Blood glucose increasedFAERS: 26US FAERS
36Chest PainFAERS: 26SIDER
US FAERS
37Diabetes MellitusFAERS: 25SIDER
US FAERS
38ConstipationFAERS: 24SIDER
US FAERS
39DroolingFAERS: 24
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
40Intentional self-injuryFAERS: 23US FAERS
41ParanoiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
42SyncopeFAERS: 21
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
43Cerebrovascular accidentFAERS: 20
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
44HypotensionFAERS: 20SIDER
US FAERS
45PainFAERS: 20
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
46Drug prescribing errorFAERS: 19OFFSIDES
US FAERS
47Erectile dysfunctionFAERS: 19
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
48Blood creatine phosphokinase increasedFAERS: 18SIDER
US FAERS
49DeliriumFAERS: 18US FAERS
50HypersensitivityFAERS: 18SIDER
US FAERS
51Incorrect dose administeredFAERS: 18US FAERS
52Pulmonary EmbolismFAERS: 18SIDER
US FAERS
53RhabdomyolysisFAERS: 18SIDER
US FAERS
54Weight decreasedFAERS: 18
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
55Chest discomfortFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
56Drug dispensing errorFAERS: 17US FAERS
57Memory impairmentFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
58CatatoniaFAERS: 16OFFSIDES
US FAERS
59HypersomniaFAERS: 16US FAERS
60Muscle RigidityFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
61PneumoniaFAERS: 16SIDER
US FAERS
62Urinary IncontinenceFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
63Drug administration errorFAERS: 15OFFSIDES
US FAERS
64LethargyFAERS: 15
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
65LeukopeniaFAERS: 15SIDER
US FAERS
66Myocardial InfarctionFAERS: 15US FAERS
67UrticariaFAERS: 15SIDER
US FAERS
68DysarthriaFAERS: 14SIDER
US FAERS
69Product quality issueFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
70TrismusFAERS: 14SIDER
US FAERS
71Visual ImpairmentFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
72White blood cell count decreasedFAERS: 14SIDER
US FAERS
73Mental impairmentFAERS: 13US FAERS
74MyalgiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
75Poor quality sleepFAERS: 13OFFSIDES
US FAERS
76PruritusFAERS: 13SIDER
US FAERS
77AngerFAERS: 12US FAERS
78NeutropeniaFAERS: 12SIDER
US FAERS
79Alanine Aminotransferase IncreasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
80Therapeutic response unexpectedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
81Therapy cessationFAERS: 11US FAERS
82Breast tendernessFAERS: 10OFFSIDES
SIDER
US FAERS
83Cardiac ArrestFAERS: 10SIDER
US FAERS
84ChillsFAERS: 10SIDER
US FAERS
85Intentional drug misuseFAERS: 10US FAERS
86Medication residue presentFAERS: 10US FAERS
87PancreatitisFAERS: 10SIDER
US FAERS
88PriapismFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
89Psychiatric symptomFAERS: 10US FAERS
90Sexual DysfunctionFAERS: 10SIDER
US FAERS
91SluggishnessFAERS: 10US FAERS
92ThrombosisFAERS: 10US FAERS
93Accidental drug intake by childFAERS: 9OFFSIDES
US FAERS
94ApathyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
95ArthralgiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
96Depressed moodFAERS: 9US FAERS
97NervousnessFAERS: 9
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
98Back PainFAERS: 8SIDER
US FAERS
99Blood cholesterol increasedFAERS: 8SIDER
US FAERS
100Blood triglycerides increasedFAERS: 8SIDER
US FAERS
101ChokingFAERS: 8US FAERS
102CryingFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
103Drug abuseFAERS: 8US FAERS
104Eye painFAERS: 8US FAERS
105HungerFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
106Mental status changesFAERS: 8US FAERS
107Oculogyric crisisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
108Oropharyngeal painFAERS: 8US FAERS
109Abdominal discomfortFAERS: 7SIDER
US FAERS
110AmnesiaFAERS: 7US FAERS
111BradycardiaFAERS: 7SIDER
US FAERS
112BradyphreniaFAERS: 7US FAERS
113Drug DependenceFAERS: 7US FAERS
114ErythemaFAERS: 7SIDER
US FAERS
115Expired drug administeredFAERS: 7OFFSIDES
US FAERS
116Medication residueFAERS: 7US FAERS
117Product availability issueFAERS: 7US FAERS
118SepsisFAERS: 7US FAERS
119ThirstFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
120ThrombocytopeniaFAERS: 7SIDER
US FAERS
121Unevaluable eventFAERS: 7US FAERS
122Activities of daily living impairedFAERS: 6US FAERS
123AnorexiaFAERS: 6SIDER
US FAERS
124Drug screen positiveFAERS: 6OFFSIDES
US FAERS
125Emotional distressFAERS: 6US FAERS
126FractureFAERS: 6US FAERS
127General physical health deteriorationFAERS: 6US FAERS
128Inappropriate schedule of product administrationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
129Injection site painFAERS: 6SIDER
US FAERS
130Intestinal ObstructionFAERS: 6SIDER
US FAERS
131Joint stiffnessFAERS: 6OFFSIDES
SIDER
US FAERS
132Joint swellingFAERS: 6SIDER
US FAERS
133Nonspecific reactionFAERS: 6US FAERS
134PancytopeniaFAERS: 6US FAERS
135PhotophobiaFAERS: 6SIDER
US FAERS
136PolydipsiaFAERS: 6SIDER
US FAERS
137Schizoaffective DisorderFAERS: 6OFFSIDES
US FAERS
138StressFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
139Urinary RetentionFAERS: 6SIDER
US FAERS
140Ventricular FibrillationFAERS: 6OFFSIDES
SIDER
US FAERS
141AbasiaFAERS: 5OFFSIDES
US FAERS
142Accidental exposure to product by childFAERS: 5US FAERS
143Accidental overdoseFAERS: 5US FAERS
144AlopeciaFAERS: 5SIDER
US FAERS
145AphasiaFAERS: 5US FAERS
146Aspartate Aminotransferase IncreasedFAERS: 5SIDER
US FAERS
147Atrioventricular BlockFAERS: 5SIDER
US FAERS
148Blood creatinine increasedFAERS: 5US FAERS
149Cogwheel RigidityFAERS: 5SIDER
US FAERS
150Deep Vein ThrombosisFAERS: 5SIDER
US FAERS
151Depressed Level of ConsciousnessFAERS: 5SIDER
US FAERS
152DiscomfortFAERS: 5SIDER
US FAERS
153DisorientationFAERS: 5US FAERS
154Drug ineffective for unapproved indicationFAERS: 5US FAERS
155DysgeusiaFAERS: 5OFFSIDES
SIDER
US FAERS
156DyspepsiaFAERS: 5SIDER
US FAERS
157DysphemiaFAERS: 5US FAERS
158HypokinesiaFAERS: 5SIDER
US FAERS
159InfectionFAERS: 5SIDER
US FAERS
160Mood swingsFAERS: 5US FAERS
161ObesityFAERS: 5US FAERS
162Obsessive-Compulsive DisorderFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
163Product dose omissionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
164Respiratory FailureFAERS: 5US FAERS
165Sudden deathFAERS: 5SIDER
US FAERS
166SwellingFAERS: 5SIDER
US FAERS
167Toxicity to various agentsFAERS: 5US FAERS
168Urinary tract infectionFAERS: 5SIDER
US FAERS
169VertigoFAERS: 5SIDER
US FAERS
170Wrong technique in product usage processFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
171Abdominal PainFAERS: 4SIDER
US FAERS
172Angina PectorisFAERS: 4US FAERS
173Atrial FibrillationFAERS: 4SIDER
US FAERS
174Autonomic nervous system imbalanceFAERS: 4US FAERS
175BlindnessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
176Blood sodium decreasedFAERS: 4US FAERS
177Body temperature fluctuationFAERS: 4US FAERS
178Device leakageFAERS: 4US FAERS
179Diabetic KetoacidosisFAERS: 4SIDER
US FAERS
180Drug level decreasedFAERS: 4US FAERS
181Drug withdrawal syndromeFAERS: 4SIDER
US FAERS
182DysphoniaFAERS: 4SIDER
US FAERS
183DysuriaFAERS: 4SIDER
US FAERS
184EpistaxisFAERS: 4SIDER
US FAERS
185Erythema MultiformeFAERS: 4US FAERS
186Extra dose administeredFAERS: 4US FAERS
187Gamma-Glutamyltransferase IncreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
188HostilityFAERS: 4US FAERS
189IleusFAERS: 4SIDER
US FAERS
190Impaired work abilityFAERS: 4US FAERS
191Lactation DisorderFAERS: 4OFFSIDES
US FAERS
192Muscle tightnessFAERS: 4OFFSIDES
SIDER
US FAERS
193NasopharyngitisFAERS: 4SIDER
US FAERS
194Neck PainFAERS: 4SIDER
US FAERS
195NephrolithiasisFAERS: 4OFFSIDES
US FAERS
196Neutrophil count decreasedFAERS: 4US FAERS
197Restless Legs SyndromeFAERS: 4SIDER
US FAERS
198Retinal DetachmentFAERS: 4US FAERS
199Skin lacerationFAERS: 4US FAERS
200StaringFAERS: 4OFFSIDES
US FAERS
201TensionFAERS: 4
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
202TorticollisFAERS: 4SIDER
US FAERS
203treatment failureFAERS: 4US FAERS
204AkinesiaFAERS: 3SIDER
US FAERS
205Anaphylactoid ReactionFAERS: 3US FAERS
206AngioedemaFAERS: 3SIDER
US FAERS
207AnorgasmiaFAERS: 3OFFSIDES
SIDER
US FAERS
208AphoniaFAERS: 3OFFSIDES
US FAERS
209AtaxiaFAERS: 3US FAERS
210BlepharospasmFAERS: 3OFFSIDES
SIDER
US FAERS
211Blood pressure fluctuationFAERS: 3US FAERS
212BruxismFAERS: 3US FAERS
213Burning sensationFAERS: 3US FAERS
214Cardiac DeathFAERS: 3OFFSIDES
US FAERS
215Cerebral InfarctionFAERS: 3US FAERS
216Consciousness fluctuatingFAERS: 3US FAERS
217Creatinine renal clearance decreasedFAERS: 3US FAERS
218DehydrationFAERS: 3US FAERS
219DementiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
220DependenceFAERS: 3US FAERS
221DiplopiaFAERS: 3US FAERS
222Drug effect incompleteFAERS: 3US FAERS
223Drug level increasedFAERS: 3US FAERS
224EpilepsyFAERS: 3US FAERS
225Expired product administeredFAERS: 3US FAERS
226FlushingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
227HepatitisFAERS: 3US FAERS
228HerniaFAERS: 3US FAERS
229HypometabolismFAERS: 3US FAERS
230HypophagiaFAERS: 3US FAERS
231Impaired driving abilityFAERS: 3US FAERS
232ImpatienceFAERS: 3OFFSIDES
US FAERS
233Injection site noduleFAERS: 3US FAERS
234LeukocytosisFAERS: 3US FAERS
235Lip swellingFAERS: 3US FAERS
236Loss of personal independence in daily activitiesFAERS: 3US FAERS
237Low density lipoprotein abnormalFAERS: 3US FAERS
238Negative thoughtsFAERS: 3US FAERS
239Night sweatsFAERS: 3US FAERS
240Oropharyngeal spasmFAERS: 3OFFSIDES
SIDER
US FAERS
241Physical assaultFAERS: 3US FAERS
242Product dispensing errorFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
243Product packaging issueFAERS: 3US FAERS
244Psychotic symptomFAERS: 3US FAERS
245Respiratory DepressionFAERS: 3US FAERS
246Serotonin SyndromeFAERS: 3US FAERS
247Sinus TachycardiaFAERS: 3SIDER
US FAERS
248SoliloquyFAERS: 3US FAERS
249Stevens-Johnson SyndromeFAERS: 3US FAERS
250StomatitisFAERS: 3US FAERS
251Temperature intoleranceFAERS: 3OFFSIDES
US FAERS
252Therapy changeFAERS: 3US FAERS
253ThrombophlebitisFAERS: 3US FAERS
254Transaminases increasedFAERS: 3SIDER
US FAERS
255Unresponsive to stimuliFAERS: 3SIDER
US FAERS
256Visual disturbanceFAERS: 3US FAERS
257Accidental exposureFAERS: 2US FAERS
258Acne ConglobataFAERS: 2OFFSIDES
US FAERS
259AcneFAERS: 2SIDER
US FAERS
260Acute myocardial infarctionFAERS: 2US FAERS
261Acute psychosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
262AgeusiaFAERS: 2OFFSIDES
US FAERS
263Alopecia AreataFAERS: 2US FAERS
264Altered state of consciousnessFAERS: 2SIDER
US FAERS
265Anticholinergic SyndromeFAERS: 2US FAERS
266AsphyxiaFAERS: 2US FAERS
267AsthmaFAERS: 2US FAERS
268Bipolar DisorderFAERS: 2SIDER
US FAERS
269Bipolar I disorderFAERS: 2SIDER
US FAERS
270BlepharitisFAERS: 2OFFSIDES
US FAERS
271Blood glucose decreasedFAERS: 2US FAERS
272Blood lactate dehydrogenase increasedFAERS: 2US FAERS
273Blood testosterone decreasedFAERS: 2OFFSIDES
SIDER
US FAERS
274Blood urea increasedFAERS: 2US FAERS
275Blood urine presentFAERS: 2US FAERS
276Blunted affectFAERS: 2SIDER
US FAERS
277Breast cancer stage IIFAERS: 2OFFSIDES
US FAERS
278Breast engorgementFAERS: 2SIDER
US FAERS
279BronchopneumoniaFAERS: 2US FAERS
280Bulimia NervosaFAERS: 2US FAERS
281Cerebral disorderFAERS: 2US FAERS
282DermatitisFAERS: 2SIDER
US FAERS
283Diabetes InsipidusFAERS: 2US FAERS
284Dissociative Identity DisorderFAERS: 2US FAERS
285Drug exposure during pregnancyFAERS: 2US FAERS
286DyspareuniaFAERS: 2OFFSIDES
US FAERS
287Ear discomfortFAERS: 2US FAERS
288Electrocardiogram ST-T changeFAERS: 2US FAERS
289Electrocardiogram changeFAERS: 2US FAERS
290EnuresisFAERS: 2US FAERS
291Euphoric moodFAERS: 2US FAERS
292Excessive masturbationFAERS: 2US FAERS
293Eye irritationFAERS: 2US FAERS
294Facial paralysisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
295Failure of child resistant mechanism for pharmaceutical productFAERS: 2OFFSIDES
US FAERS
296Feeling jitteryFAERS: 2US FAERS
297GastritisFAERS: 2US FAERS
298Gastrointestinal stoma complicationFAERS: 2US FAERS
299Hallucinations, mixedFAERS: 2US FAERS
300Head discomfortFAERS: 2US FAERS
301Heat illnessFAERS: 2US FAERS
302HemiparesisFAERS: 2US FAERS
303Hepatitis CFAERS: 2US FAERS
304HomicideFAERS: 2US FAERS
305HyperphagiaFAERS: 2US FAERS
306Hypertensive crisisFAERS: 2US FAERS
307HyperthyroidismFAERS: 2US FAERS
308HypomaniaFAERS: 2US FAERS
309Hypothalamo-pituitary disorderFAERS: 2US FAERS
310ImmobileFAERS: 2US FAERS
311IncontinenceFAERS: 2OFFSIDES
US FAERS
312InfluenzaFAERS: 2SIDER
US FAERS
313Injection site massFAERS: 2US FAERS
314Intentional product misuseFAERS: 2US FAERS
315LacerationFAERS: 2US FAERS
316LaryngospasmFAERS: 2OFFSIDES
SIDER
US FAERS
317Lymphocyte count decreasedFAERS: 2US FAERS
318Mastication disorderFAERS: 2US FAERS
319Medication ErrorFAERS: 2US FAERS
320MeningitisFAERS: 2US FAERS
321MonoplegiaFAERS: 2US FAERS
322Muscle tone disorderFAERS: 2US FAERS
323Musculoskeletal chest painFAERS: 2US FAERS
324MydriasisFAERS: 2US FAERS
325MyocarditisFAERS: 2US FAERS
326Nipple painFAERS: 2OFFSIDES
US FAERS
327Obsessive thoughtsFAERS: 2US FAERS
328Pericardial effusionFAERS: 2US FAERS
329Physical product label issueFAERS: 2US FAERS
330PleurothotonusFAERS: 2SIDER
US FAERS
331Prescribed overdoseFAERS: 2US FAERS
332PresyncopeFAERS: 2US FAERS
333Product counterfeitFAERS: 2US FAERS
334Product solubility abnormalFAERS: 2US FAERS
335Product substitution issueFAERS: 2US FAERS
336PrurigoFAERS: 2US FAERS
337PsoriasisFAERS: 2US FAERS
338Respiratory distressFAERS: 2SIDER
US FAERS
339Resting TremorFAERS: 2US FAERS
340RetchingFAERS: 2US FAERS
341ScabFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
342Secondary ticFAERS: 2US FAERS
343Septic ShockFAERS: 2US FAERS
344SinusitisFAERS: 2SIDER
US FAERS
345SnoringFAERS: 2US FAERS
346SoporFAERS: 2OFFSIDES
US FAERS
347StarvationFAERS: 2OFFSIDES
US FAERS
348Sudden Cardiac DeathFAERS: 2US FAERS
349SunburnFAERS: 2US FAERS
350Syringe issueFAERS: 2US FAERS
351TachyarrhythmiaFAERS: 2US FAERS
352TachyphreniaFAERS: 2US FAERS
353Throat irritationFAERS: 2US FAERS
354TinnitusFAERS: 2SIDER
US FAERS
355Water IntoxicationFAERS: 2SIDER
US FAERS
356nervous system disorderFAERS: 2SIDER
US FAERS
357Abdominal rigidityFAERS: 1US FAERS
358Abnormal withdrawal bleedingFAERS: 1US FAERS
359AbscessFAERS: 1US FAERS
360Accidental exposure to productFAERS: 1US FAERS
361AgranulocytosisFAERS: 1SIDER
US FAERS
362Alcohol abuseFAERS: 1OFFSIDES
US FAERS
363Alcohol poisoningFAERS: 1US FAERS
364Ammonia increasedFAERS: 1US FAERS
365Anal FissureFAERS: 1US FAERS
366Anaphylactic shockFAERS: 1SIDER
US FAERS
367Angle Closure GlaucomaFAERS: 1US FAERS
368AnhedoniaFAERS: 1US FAERS
369AnosognosiaFAERS: 1US FAERS
370Antipsychotic drug level increasedFAERS: 1US FAERS
371AphagiaFAERS: 1US FAERS
372Apparent deathFAERS: 1US FAERS
373ArthropathyFAERS: 1US FAERS
374Arthropod biteFAERS: 1US FAERS
375AscitesFAERS: 1US FAERS
376AsterixisFAERS: 1US FAERS
377Autonomic neuropathyFAERS: 1US FAERS
378AzoospermiaFAERS: 1US FAERS
379Benign Prostatic HyperplasiaFAERS: 1US FAERS
380Biliary ColicFAERS: 1US FAERS
381Blood arsenic increasedFAERS: 1US FAERS
382Blood growth hormone increasedFAERS: 1US FAERS
383Blood potassium decreasedFAERS: 1US FAERS
384Blood triglycerides decreasedFAERS: 1US FAERS
385Bone painFAERS: 1US FAERS
386Bowel movement irregularityFAERS: 1US FAERS
387BradykinesiaFAERS: 1SIDER
US FAERS
388Brain ContusionFAERS: 1US FAERS
389Brain DeathFAERS: 1US FAERS
390Bronchial ObstructionFAERS: 1US FAERS
391BronchitisFAERS: 1SIDER
US FAERS
392BronchospasmFAERS: 1US FAERS
393Cardiac TamponadeFAERS: 1US FAERS
394Cardiovascular insufficiencyFAERS: 1OFFSIDES
US FAERS
395CataractFAERS: 1US FAERS
396Cerebral atrophyFAERS: 1US FAERS
397Cerebral hygromaFAERS: 1US FAERS
398Choking sensationFAERS: 1US FAERS
399CholestasisFAERS: 1US FAERS
400ChromatopsiaFAERS: 1US FAERS
401ChromaturiaFAERS: 1US FAERS
402Compulsive sexual behaviourFAERS: 1US FAERS
403Compulsive shoppingFAERS: 1US FAERS
404ConjunctivitisFAERS: 1SIDER
US FAERS
405Coronary Artery DiseaseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
406Coronary artery insufficiencyFAERS: 1US FAERS
407Counterfeit drug administeredFAERS: 1US FAERS
408DeafnessFAERS: 1US FAERS
409Dental cariesFAERS: 1US FAERS
410DisabilityFAERS: 1US FAERS
411Disease recurrenceFAERS: 1US FAERS
412DiverticulitisFAERS: 1US FAERS
413Drug administered at inappropriate siteFAERS: 1US FAERS
414Drug resistanceFAERS: 1US FAERS
415Dry skinFAERS: 1SIDER
US FAERS
416DysgraphiaFAERS: 1US FAERS
417Dysthymic DisorderFAERS: 1OFFSIDES
US FAERS
418EczemaFAERS: 1SIDER
US FAERS
419Educational problemFAERS: 1US FAERS
420Electroencephalogram abnormalFAERS: 1US FAERS
421Electrolyte imbalanceFAERS: 1US FAERS
422Emergency CareFAERS: 1US FAERS
423EncephalitisFAERS: 1US FAERS
424Enterococcal sepsisFAERS: 1US FAERS
425Erection increasedFAERS: 1US FAERS
426Escherichia sepsisFAERS: 1US FAERS
427Excessive eye blinkingFAERS: 1US FAERS
428Exfoliative rashFAERS: 1US FAERS
429Extremity necrosisFAERS: 1OFFSIDES
US FAERS
430Eyelid Function DisorderFAERS: 1OFFSIDES
US FAERS
431Facial PainFAERS: 1US FAERS
432Feeling ColdFAERS: 1US FAERS
433Feelings of worthlessnessFAERS: 1US FAERS
434Fibrin D dimer increasedFAERS: 1US FAERS
435FibromyalgiaFAERS: 1US FAERS
436FlatulenceFAERS: 1OFFSIDES
SIDER
US FAERS
437Foaming at mouthFAERS: 1US FAERS
438Food cravingFAERS: 1US FAERS
439Freezing phenomenonFAERS: 1US FAERS
440FrustrationFAERS: 1US FAERS
441GangreneFAERS: 1US FAERS
442Gastric ulcerFAERS: 1US FAERS
443Gastrointestinal motility disorderFAERS: 1US FAERS
444Gaze palsyFAERS: 1US FAERS
445General symptomFAERS: 1US FAERS
446GlaucomaFAERS: 1SIDER
US FAERS
447GlossitisFAERS: 1OFFSIDES
US FAERS
448Gluten sensitivityFAERS: 1US FAERS
449Hair injuryFAERS: 1US FAERS
450HemiplegiaFAERS: 1US FAERS
451HepatomegalyFAERS: 1US FAERS
452HepatotoxicityFAERS: 1US FAERS
453Hormone level abnormalFAERS: 1US FAERS
454HydronephrosisFAERS: 1US FAERS
455HyperacusisFAERS: 1US FAERS
456HypercatabolismFAERS: 1US FAERS
457HypertransaminasaemiaFAERS: 1US FAERS
458HypervigilanceFAERS: 1US FAERS
459Hypoaesthesia facialFAERS: 1US FAERS
460HypochondriasisFAERS: 1US FAERS
461HypothyroidismFAERS: 1US FAERS
462IlliteracyFAERS: 1US FAERS
463Inappropriate affectFAERS: 1US FAERS
464IncoherentFAERS: 1US FAERS
465Incorrect product storageFAERS: 1US FAERS
466Incorrect route of drug administrationFAERS: 1US FAERS
467Incorrect storage of drugFAERS: 1US FAERS
468InfarctionFAERS: 1US FAERS
469Initial insomniaFAERS: 1SIDER
US FAERS
470Injection site cellulitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
471Injection site erythemaFAERS: 1US FAERS
472Injection site infectionFAERS: 1US FAERS
473Injection site pruritusFAERS: 1US FAERS
474Injection site warmthFAERS: 1US FAERS
475Insulin-requiring type 2 diabetes mellitusFAERS: 1US FAERS
476Intention tremorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
477Intentional product use issueFAERS: 1US FAERS
478KetoacidosisFAERS: 1US FAERS
479LazinessFAERS: 1US FAERS
480Life expectancy shortenedFAERS: 1US FAERS
481Limb discomfortFAERS: 1US FAERS
482Long QT SyndromeFAERS: 1US FAERS
483Low density lipoprotein increasedFAERS: 1US FAERS
484Lower respiratory tract infectionFAERS: 1US FAERS
485LymphadenopathyFAERS: 1US FAERS
486MalabsorptionFAERS: 1US FAERS
487MalnutritionFAERS: 1SIDER
US FAERS
488MastitisFAERS: 1US FAERS
489Maternal exposure during pregnancyFAERS: 1US FAERS
490MenopauseFAERS: 1US FAERS
491MenorrhagiaFAERS: 1SIDER
US FAERS
492Mental FatigueFAERS: 1US FAERS
493MetrorrhagiaFAERS: 1US FAERS
494Morbid thoughtsFAERS: 1US FAERS
495Multiple allergiesFAERS: 1US FAERS
496Multiple drug overdoseFAERS: 1US FAERS
497Muscle SpasticityFAERS: 1US FAERS
498MutismFAERS: 1US FAERS
499MyopiaFAERS: 1US FAERS
500MyotoniaFAERS: 1SIDER
US FAERS
501NeuralgiaFAERS: 1US FAERS
502Neurotransmitter level alteredFAERS: 1US FAERS
503NoduleFAERS: 1US FAERS
504Ocular discomfortFAERS: 1US FAERS
505Ocular icterusFAERS: 1US FAERS
506OphthalmoplegiaFAERS: 1US FAERS
507Optic AtrophyFAERS: 1US FAERS
508Oropharyngeal swellingFAERS: 1US FAERS
509OsteoporosisFAERS: 1US FAERS
510Pancreatic Enzymes DecreasedFAERS: 1US FAERS
511Panic DisorderFAERS: 1US FAERS
512ParamnesiaFAERS: 1US FAERS
513Paroxysmal perceptual alterationFAERS: 1US FAERS
514Performance status decreasedFAERS: 1US FAERS
515Peripheral embolismFAERS: 1US FAERS
516Peripheral swellingFAERS: 1US FAERS
517PetechiaeFAERS: 1US FAERS
518Pharmaceutical product complaintFAERS: 1US FAERS
519Physical abuseFAERS: 1US FAERS
520Physical deconditioningFAERS: 1US FAERS
521Pituitary gonadotropin hyperfunctionFAERS: 1US FAERS
522PleuropericarditisFAERS: 1US FAERS
523Pneumatosis intestinalisFAERS: 1US FAERS
524PoisoningFAERS: 1US FAERS
525Poor quality drug administeredFAERS: 1US FAERS
526Portal HypertensionFAERS: 1US FAERS
527Portal venous gasFAERS: 1US FAERS
528Post-injection delirium sedation syndromeFAERS: 1US FAERS
529Postural Orthostatic Tachycardia SyndromeFAERS: 1SIDER
US FAERS
530Poverty of speechFAERS: 1US FAERS
531Premature EjaculationFAERS: 1US FAERS
532Pressure of speechFAERS: 1US FAERS
533Product coating issueFAERS: 1US FAERS
534Product label issueFAERS: 1US FAERS
535Product prescribing errorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
536Product residue presentFAERS: 1US FAERS
537Product use complaintFAERS: 1US FAERS
538Productive CoughFAERS: 1US FAERS
539ProlactinomaFAERS: 1US FAERS
540Protein total abnormalFAERS: 1US FAERS
541Psychomotor skills impairedFAERS: 1OFFSIDES
US FAERS
542Pulmonary InfarctionFAERS: 1US FAERS
543Pulmonary thrombosisFAERS: 1US FAERS
544Rash erythematousFAERS: 1US FAERS
545Respiratory arrestFAERS: 1US FAERS
546Retrograde ejaculationFAERS: 1SIDER
US FAERS
547Rotator cuff syndromeFAERS: 1US FAERS
548ScreamingFAERS: 1US FAERS
549SeminomaFAERS: 1US FAERS
550ShockFAERS: 1SIDER
US FAERS
551Sinus bradycardiaFAERS: 1US FAERS
552Skin lesionFAERS: 1US FAERS
553Skin reactionFAERS: 1US FAERS
554Sleep disorder therapyFAERS: 1US FAERS
555Slow response to stimuliFAERS: 1US FAERS
556SmokerFAERS: 1OFFSIDES
US FAERS
557SneezingFAERS: 1US FAERS
558SomnambulismFAERS: 1US FAERS
559Sperm concentration zeroFAERS: 1US FAERS
560Status EpilepticusFAERS: 1US FAERS
561StrabismusFAERS: 1US FAERS
562StuporFAERS: 1SIDER
US FAERS
563Supraventricular tachycardiaFAERS: 1US FAERS
564Suspected counterfeit productFAERS: 1US FAERS
565Suspected product tamperingFAERS: 1US FAERS
566Tablet physical issueFAERS: 1US FAERS
567Tension HeadacheFAERS: 1US FAERS
568Therapeutic product ineffectiveFAERS: 1US FAERS
569Therapeutic response changedFAERS: 1US FAERS
570Tobacco userFAERS: 1US FAERS
571Tongue spasmFAERS: 1SIDER
US FAERS
572Tooth LossFAERS: 1US FAERS
573Toxic Epidermal NecrolysisFAERS: 1US FAERS
574Trisomy 21FAERS: 1US FAERS
575UveitisFAERS: 1US FAERS
576Vein painFAERS: 1US FAERS
577Violence-related symptomFAERS: 1US FAERS
578Waist circumference increasedFAERS: 1SIDER
US FAERS
579Wheelchair userFAERS: 1US FAERS
580Wrong drug administeredFAERS: 1US FAERS
581YawningFAERS: 1US FAERS
582jaundiceFAERS: 1SIDER
US FAERS
583Abdominal Compartment SyndromeOFFSIDES
584Abnormal visionOFFSIDES
585AcarodermatitisSIDER
586AdenocarcinomaSIDER
587AlbinismSIDER
588AmenorrheaOFFSIDES
589AmphetaminesOFFSIDES
590AnosmiaOFFSIDES
591Arterial thrombosisOFFSIDES
592AthetosisSIDER
593AuraOFFSIDES
594Bladder painSIDER
595Blood and lymphatic system disordersSIDER
596Blood creatine phosphokinase decreasedOFFSIDES
597Blood lactate dehydrogenase decreasedOFFSIDES
598BoredomCanada Vigilance: 1Canada Vigilance
OFFSIDES
599Breast FeedingSIDER
600Breast discomfortSIDER
601CellulitisSIDER
602CheilitisSIDER
603ChoreaSIDER
604ChoreoathetosisSIDER
605Colonic Pseudo-ObstructionOFFSIDES
606ContractureOFFSIDES
607CystitisSIDER
608CystCanada Vigilance: 1Canada Vigilance
609Decreased LibidoOFFSIDES
610Delusional disorder, persecutory typeCanada Vigilance: 1Canada Vigilance
611Depression suicidalOFFSIDES
612Disturbance in sexual arousalSIDER
613Drug withdrawal headacheOFFSIDES
614Ear and labyrinth disordersSIDER
615Ejaculation inhibitedSIDER
616Electrocardiogram abnormalSIDER
617EmprosthotonusSIDER
618EndophthalmitisSIDER
619Essential HypertensionOFFSIDES
620Eye InfectionSIDER
621Flight of ideasOFFSIDES
622Floppy iris syndromeSIDER
623GalactorrheaOFFSIDES
624GastroenteritisSIDER
625Gastrointestinal PainSIDER
626Gastrointestinal obstructionSIDER
627Glabellar reflex abnormalSIDER
628GlycosuriaSIDER
629Head BangingOFFSIDES
630Head titubationOFFSIDES
SIDER
631HyperinsulinismSIDER
632HyperkeratosisSIDER
633HyperkinesiaSIDER
634HyperventilationSIDER
635Increased prolactin levelSIDER
636IndurationSIDER
637InfestationSIDER
638Injection Site ReactionSIDER
639Injection site abscessCanada Vigilance: 1Canada Vigilance
640Insulin C-peptide increasedSIDER
641Jealous delusionOFFSIDES
642Libido disorderCanada Vigilance: 1Canada Vigilance
643Male sexual dysfunctionCanada Vigilance: 1Canada Vigilance
644Middle insomniaSIDER
645Multiple drug overdose intentionalOFFSIDES
646Muscle WeaknessOFFSIDES
647Muscle relaxant therapySIDER
648Musculoskeletal PainSIDER
649Musculoskeletal discomfortSIDER
650MyoclonusSIDER
651MyopericarditisOFFSIDES
652Nicotine DependenceCanada Vigilance: 1Canada Vigilance
653Nuchal RigiditySIDER
654OculogyrationSIDER
655OnychomycosisSIDER
656OpisthotonusSIDER
657Oromandibular dystoniaSIDER
658Pain during injectionSIDER
659Pancreatic NeoplasmSIDER
660Parkinsonian rest tremorSIDER
661Perivascular dermatitisOFFSIDES
662Pharyngolaryngeal PainSIDER
663Pitting edemaSIDER
664PregnancySIDER
665Product complaintCanada Vigilance: 1Canada Vigilance
666Pulmonary congestionSIDER
667RalesSIDER
668RednessSIDER
669Respiratory TherapyOFFSIDES
670Respiratory tract congestionSIDER
671RhinitisSIDER
672Risus sardonicusOFFSIDES
SIDER
673Senile dementiaOFFSIDES
674Serum prolactin increasedSIDER
675Serum testosterone decreasedSIDER
676Shoulder PainSIDER
677Sinus ArrhythmiaSIDER
678StillbirthSIDER
679SuicideSIDER
680TetanyOFFSIDES
SIDER
681Therapeutic product effect incompleteCanada Vigilance: 1Canada Vigilance
682Therapy non-responderCanada Vigilance: 1Canada Vigilance
683Tongue blisteringOFFSIDES
684TonsillitisSIDER
685ToothacheSIDER
686Umbilical herniaOFFSIDES
687Upset stomachSIDER
688Vaginal DischargeSIDER
689Venous ThromboembolismSIDER
690Venous ThrombosisSIDER
691Ventricular arrhythmiaSIDER
692Vitreous opacitiesOFFSIDES
693Vulvovaginal pruritusOFFSIDES
694Walking aid userOFFSIDES
695Weight GainOFFSIDES
696WheezingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.